Cargando…
Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
AIM: The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067780/ https://www.ncbi.nlm.nih.gov/pubmed/30100760 http://dx.doi.org/10.2147/CLEP.S151890 |
_version_ | 1783343170587721728 |
---|---|
author | Moulis, Guillaume Ibañez, Berta Palmaro, Aurore Aizpuru, Felipe Millan, Eduardo Lapeyre-Mestre, Maryse Sailler, Laurent Cambra, Koldo |
author_facet | Moulis, Guillaume Ibañez, Berta Palmaro, Aurore Aizpuru, Felipe Millan, Eduardo Lapeyre-Mestre, Maryse Sailler, Laurent Cambra, Koldo |
author_sort | Moulis, Guillaume |
collection | PubMed |
description | AIM: The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence of type 2 diabetes mellitus (T2DM) in Navarre and the Basque Country (Spain) and the Midi-Pyrénées region (France). PATIENTS AND METHODS: We described and compared database structures and the availability of hospital, outpatient, and drug-dispensing data from 5.9 million inhabitants. Due to differences in database structures and recorded data, we could not develop a common procedure to estimate T2DM prevalence, but identified an algorithm specific to each database. Patients were identified using primary care diagnosis codes previously validated in Spanish databases and a combination of primary care diagnosis codes, hospital diagnosis codes, and data on exposure to oral antidiabetic drugs from the French database. RESULTS: Spanish and French databases (the latter termed Système National d’Information Inter-Régimes de l’Assurance Maladie [SNIIRAM]) included demographic, primary care diagnoses, hospital diagnoses, and outpatient drug-dispensing data. Diagnoses were encoded using the International Classification of Primary Care (version 2) and the International Classification of Diseases, version 9 and version 10 (ICD-9 and ICD-10) in the Spanish databases, whereas the SNIIRAM contained ICD-10 codes. All data were anonymized before transferring to researchers. T2DM prevalence in the population over 20 years was estimated to be 6.6–7.0% in the Spanish regions and 6.3% in the Midi-Pyrénées region with ~2% higher estimates for males in the three regions. CONCLUSION: Tailored procedures can be designed to estimate the prevalence of T2DM in population-based studies from Spanish and French electronic health care records. |
format | Online Article Text |
id | pubmed-6067780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60677802018-08-10 Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus Moulis, Guillaume Ibañez, Berta Palmaro, Aurore Aizpuru, Felipe Millan, Eduardo Lapeyre-Mestre, Maryse Sailler, Laurent Cambra, Koldo Clin Epidemiol Original Research AIM: The EPICHRONIC (EPIdemiology of CHRONIC diseases) project investigated the possibility of developing common procedures for French and Spanish electronic health care databases to enable large-scale pharmacoepidemiological studies on chronic diseases. A feasibility study assessed the prevalence of type 2 diabetes mellitus (T2DM) in Navarre and the Basque Country (Spain) and the Midi-Pyrénées region (France). PATIENTS AND METHODS: We described and compared database structures and the availability of hospital, outpatient, and drug-dispensing data from 5.9 million inhabitants. Due to differences in database structures and recorded data, we could not develop a common procedure to estimate T2DM prevalence, but identified an algorithm specific to each database. Patients were identified using primary care diagnosis codes previously validated in Spanish databases and a combination of primary care diagnosis codes, hospital diagnosis codes, and data on exposure to oral antidiabetic drugs from the French database. RESULTS: Spanish and French databases (the latter termed Système National d’Information Inter-Régimes de l’Assurance Maladie [SNIIRAM]) included demographic, primary care diagnoses, hospital diagnoses, and outpatient drug-dispensing data. Diagnoses were encoded using the International Classification of Primary Care (version 2) and the International Classification of Diseases, version 9 and version 10 (ICD-9 and ICD-10) in the Spanish databases, whereas the SNIIRAM contained ICD-10 codes. All data were anonymized before transferring to researchers. T2DM prevalence in the population over 20 years was estimated to be 6.6–7.0% in the Spanish regions and 6.3% in the Midi-Pyrénées region with ~2% higher estimates for males in the three regions. CONCLUSION: Tailored procedures can be designed to estimate the prevalence of T2DM in population-based studies from Spanish and French electronic health care records. Dove Medical Press 2018-07-27 /pmc/articles/PMC6067780/ /pubmed/30100760 http://dx.doi.org/10.2147/CLEP.S151890 Text en © 2018 Moulis et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Moulis, Guillaume Ibañez, Berta Palmaro, Aurore Aizpuru, Felipe Millan, Eduardo Lapeyre-Mestre, Maryse Sailler, Laurent Cambra, Koldo Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus |
title | Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus |
title_full | Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus |
title_fullStr | Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus |
title_full_unstemmed | Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus |
title_short | Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus |
title_sort | cross-national health care database utilization between spain and france: results from the epichronic study assessing the prevalence of type 2 diabetes mellitus |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067780/ https://www.ncbi.nlm.nih.gov/pubmed/30100760 http://dx.doi.org/10.2147/CLEP.S151890 |
work_keys_str_mv | AT moulisguillaume crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus AT ibanezberta crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus AT palmaroaurore crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus AT aizpurufelipe crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus AT millaneduardo crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus AT lapeyremestremaryse crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus AT saillerlaurent crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus AT cambrakoldo crossnationalhealthcaredatabaseutilizationbetweenspainandfranceresultsfromtheepichronicstudyassessingtheprevalenceoftype2diabetesmellitus |